rabbit anti human tcf-4 polyclonal igg  (Santa Cruz Biotechnology)

Journal: Cancer Cell International

Article Title: Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance

doi: 10.1186/s12935-019-0764-7

Figure Lengend Snippet: Comparisons ( a ) and correlations ( b ) on expression of β-catenin, TCF-4 and survivin mRNA in NPC tissues and CNP tissues. * P < 0.05 compared with CNP tissues; TCF-4 T-cell factor-4, NPC nasopharyngeal carcinoma, CNP chronic nasopharyngitis

Article Snippet: Primary antibodies of rabbit anti-human TCF-4 (dilution of 1: 500), mouse anti-human survivin (dilution of 1: 100) and rabbit anti-human β-catenin (dilution of 1: 500) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were added and incubation was carried out overnight at 4 °C.

Techniques: Expressing

Journal: Cancer Cell International

Article Title: Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance

doi: 10.1186/s12935-019-0764-7

Figure Lengend Snippet: Immunohistochemical analysis on expression of β-catenin, TCF-4 and survivin proteins in the NPC tissues and CNP tissues (SP, ×200). TCF-4 T-cell factor-4, NPC nasopharyngeal carcinoma, SP streptavidin-perosidase, CNP chronic nasopharyngitis

Article Snippet: Primary antibodies of rabbit anti-human TCF-4 (dilution of 1: 500), mouse anti-human survivin (dilution of 1: 100) and rabbit anti-human β-catenin (dilution of 1: 500) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were added and incubation was carried out overnight at 4 °C.

Techniques: Immunohistochemical staining, Expressing

Journal: Cancer Cell International

Article Title: Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance

doi: 10.1186/s12935-019-0764-7

Figure Lengend Snippet: Kaplan-Meier survival curves of β-catenin, TCF-4 and survivin for OS, DMFS, LRFS and DFS conditions of NPC patients. a OS of NPC patients with β-catenin expression; b OS of NPC patients with TCF-4 expression; c OS of NPC patients with survivin expression; d DMFS rates of NPC patients with β-catenin expression; e DMFS rates of NPC patients with TCF-4 expression; f DMFS rates of NPC patients with survivin expression; g LRFS rates of NPC patients with β-catenin expression; h LRFS rates of NPC patients with TCF-4 expression; i LRFS rates of NPC patients with survivin expression; j DFS rates of NPC patients with β-catenin expression; k DFS rates of NPC patients with TCF-4 expression; l DFS rates of NPC patients with survivin expression; TCF-4 T-cell factor-4, NPC nasopharyngeal carcinoma, OS overall survival, DMFS distant metastasis-free survival, LRFS local recurrence-free survival, DFS disease-free survival

Article Snippet: Primary antibodies of rabbit anti-human TCF-4 (dilution of 1: 500), mouse anti-human survivin (dilution of 1: 100) and rabbit anti-human β-catenin (dilution of 1: 500) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were added and incubation was carried out overnight at 4 °C.

Techniques: Expressing